SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001279569-22-000899
Filing Date
2022-05-31
Accepted
2022-05-31 06:38:54
Documents
8
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 6-K medicure6k.htm 6-K 13150
2 Q1 FINANCIAL STATEMENTS ex991.htm EX-99.1 268481
3 Q1 MD&A ex992.htm EX-99.2 275997
4 CEO CERTIFICATION ex993.htm EX-99.3 6040
5 CFO CERTIFICATION ex994.htm EX-99.4 5879
6 GRAPHIC medicurelogo.jpg GRAPHIC 4807
7 GRAPHIC graphic1.jpg GRAPHIC 1927
8 GRAPHIC headerlogo.jpg GRAPHIC 3015
  Complete submission text file 0001279569-22-000899.txt   584372
Mailing Address SUITE 2 1250 WAVERLEY STREET WINNIPEG A2 R3T 6C6
Business Address SUITE 2 1250 WAVERLEY STREET WINNIPEG A2 R3T 6C6 204-487-7412
MEDICURE INC (Filer) CIK: 0001133519 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-31995 | Film No.: 22980370
SIC: 2834 Pharmaceutical Preparations